Tekla Capital Management as of June 30, 2015
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 108 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 8.8 | $244M | 2.1M | 117.08 | |
| Celgene Corporation | 8.1 | $223M | 1.9M | 115.74 | |
| Biogen Idec (BIIB) | 5.2 | $143M | 353k | 403.94 | |
| Mylan Nv | 4.9 | $136M | 2.0M | 67.86 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.0 | $111M | 898k | 123.48 | |
| Alexion Pharmaceuticals | 3.8 | $106M | 584k | 180.77 | |
| Allergan | 3.8 | $104M | 344k | 303.46 | |
| Amgen (AMGN) | 3.6 | $99M | 643k | 153.52 | |
| Regeneron Pharmaceuticals (REGN) | 3.5 | $96M | 187k | 510.13 | |
| Incyte Corporation (INCY) | 3.3 | $92M | 881k | 104.21 | |
| Johnson & Johnson (JNJ) | 3.1 | $86M | 885k | 97.46 | |
| Teva Pharmaceutical Industries (TEVA) | 3.0 | $82M | 1.4M | 59.10 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $73M | 535k | 136.78 | |
| Alkermes (ALKS) | 2.4 | $67M | 1.0M | 64.34 | |
| Pfizer (PFE) | 2.0 | $55M | 1.6M | 33.53 | |
| Illumina (ILMN) | 1.8 | $50M | 230k | 218.36 | |
| Aetna | 1.5 | $42M | 332k | 127.46 | |
| Akorn | 1.3 | $37M | 850k | 43.66 | |
| Bristol Myers Squibb (BMY) | 1.3 | $36M | 535k | 66.54 | |
| Endo International | 1.1 | $32M | 400k | 79.65 | |
| Catamaran | 1.0 | $27M | 434k | 61.08 | |
| Hca Holdings (HCA) | 0.9 | $25M | 280k | 90.72 | |
| Allscripts Healthcare Solutions (MDRX) | 0.9 | $24M | 1.8M | 13.68 | |
| Molina Healthcare (MOH) | 0.9 | $25M | 348k | 70.30 | |
| Esperion Therapeutics (ESPR) | 0.9 | $24M | 296k | 81.76 | |
| Receptos | 0.9 | $24M | 125k | 190.05 | |
| Acorda Therapeutics | 0.8 | $23M | 681k | 33.33 | |
| Baxter International (BAX) | 0.8 | $22M | 320k | 69.93 | |
| Humana (HUM) | 0.8 | $21M | 112k | 191.28 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.8 | $21M | 58k | 368.96 | |
| Jazz Pharmaceuticals (JAZZ) | 0.8 | $21M | 120k | 176.07 | |
| Ventas (VTR) | 0.7 | $18M | 293k | 62.09 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $18M | 376k | 47.76 | |
| Paratek Pharmaceuticals | 0.6 | $18M | 691k | 25.77 | |
| Physicians Realty Trust | 0.6 | $16M | 1.1M | 15.36 | |
| Impax Laboratories | 0.6 | $16M | 345k | 45.92 | |
| Alere | 0.6 | $16M | 298k | 52.75 | |
| Corsicanto Ltd conv bnd | 0.6 | $16M | 15M | 1.08 | |
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $16M | 370k | 41.88 | |
| Tenet Healthcare Corporation (THC) | 0.6 | $16M | 270k | 57.88 | |
| McKesson Corporation (MCK) | 0.6 | $15M | 68k | 224.81 | |
| Medical Properties Trust (MPW) | 0.6 | $15M | 1.2M | 13.11 | |
| Omega Healthcare Investors (OHI) | 0.5 | $14M | 413k | 34.33 | |
| Heron Therapeutics (HRTX) | 0.5 | $14M | 437k | 31.16 | |
| Community Health Systems (CYH) | 0.5 | $13M | 210k | 62.97 | |
| Karyopharm Therapeutics (KPTI) | 0.5 | $13M | 477k | 27.21 | |
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $12M | 104k | 119.87 | |
| CIGNA Corporation | 0.4 | $12M | 74k | 162.00 | |
| Medivation | 0.4 | $12M | 107k | 114.21 | |
| Stryker Corporation (SYK) | 0.4 | $12M | 124k | 95.57 | |
| St. Jude Medical | 0.4 | $12M | 162k | 73.07 | |
| Health Care Reit Pfd I 6.5% | 0.4 | $12M | 200k | 59.44 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $12M | 456k | 25.74 | |
| Therapeuticsmd | 0.4 | $12M | 1.5M | 7.86 | |
| Thermo Fisher Scientific (TMO) | 0.4 | $11M | 86k | 129.76 | |
| ISIS Pharmaceuticals | 0.4 | $11M | 196k | 57.55 | |
| Zimmer Holdings (ZBH) | 0.4 | $11M | 102k | 109.23 | |
| Merck & Co (MRK) | 0.4 | $11M | 185k | 56.93 | |
| Auris Med Hldg | 0.4 | $10M | 2.1M | 4.94 | |
| Pieris Pharmaceuticals | 0.4 | $11M | 3.8M | 2.75 | |
| LTC Properties (LTC) | 0.4 | $9.8M | 237k | 41.60 | |
| Sagent Pharmaceuticals | 0.4 | $10M | 410k | 24.31 | |
| Centene Corporation (CNC) | 0.3 | $9.6M | 120k | 80.40 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $9.3M | 768k | 12.06 | |
| Verastem | 0.3 | $9.4M | 1.2M | 7.54 | |
| IDEXX Laboratories (IDXX) | 0.3 | $8.5M | 132k | 64.14 | |
| Endologix | 0.3 | $8.5M | 551k | 15.34 | |
| Alliqua | 0.3 | $8.7M | 1.7M | 5.27 | |
| Senior Housing Properties Trust | 0.3 | $8.4M | 480k | 17.55 | |
| WellCare Health Plans | 0.3 | $7.5M | 89k | 84.83 | |
| Intra Cellular Therapies (ITCI) | 0.3 | $7.3M | 227k | 31.95 | |
| Merrimack Pharmaceuticals In | 0.2 | $7.0M | 568k | 12.37 | |
| Bluebird Bio (BLUE) | 0.2 | $6.9M | 41k | 168.36 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.2 | $6.7M | 2.0M | 3.33 | |
| Zogenix | 0.2 | $6.4M | 3.8M | 1.68 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $6.1M | 60k | 102.38 | |
| Allergan Plc pfd conv ser a | 0.2 | $5.2M | 5.0k | 1042.60 | |
| Achillion Pharmaceuticals | 0.2 | $4.8M | 547k | 8.86 | |
| Epizyme | 0.2 | $4.8M | 200k | 24.00 | |
| Spectrum Pharmaceuticals Inc conv | 0.2 | $4.7M | 5.0M | 0.94 | |
| Wright Medical | 0.1 | $4.1M | 156k | 26.26 | |
| Kythera Biopharmaceuticals I | 0.1 | $4.2M | 56k | 75.31 | |
| Foamix Pharmaceuticals | 0.1 | $4.2M | 414k | 10.25 | |
| Aegerion Pharmaceuticals | 0.1 | $3.9M | 206k | 18.97 | |
| Accelr8 Technology | 0.1 | $3.7M | 145k | 25.81 | |
| Flex Pharma | 0.1 | $4.0M | 233k | 17.20 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $3.1M | 1.5M | 2.10 | |
| Tetralogic Pharmaceuticals c note 8.000% 6/1 | 0.1 | $2.7M | 4.5M | 0.59 | |
| Myriad Genetics (MYGN) | 0.1 | $2.5M | 75k | 33.98 | |
| BioDelivery Sciences International | 0.1 | $2.0M | 250k | 7.96 | |
| GenMark Diagnostics | 0.1 | $1.9M | 215k | 9.06 | |
| Dermira | 0.1 | $1.7M | 97k | 17.55 | |
| Bellicum Pharma | 0.1 | $1.3M | 60k | 21.27 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $1.4M | 65k | 21.82 | |
| Cellectis S A (CLLS) | 0.1 | $1.4M | 40k | 36.08 | |
| Abaxis | 0.0 | $1.2M | 23k | 51.50 | |
| Intellipharmaceuticsintl Inc C | 0.0 | $1.0M | 354k | 2.94 | |
| Sage Therapeutics (SAGE) | 0.0 | $1.1M | 15k | 73.00 | |
| Galapagos Nv- (GLPG) | 0.0 | $1.0M | 20k | 51.50 | |
| Sangamo Biosciences (SGMO) | 0.0 | $832k | 75k | 11.09 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $701k | 50k | 14.02 | |
| Macrogenics (MGNX) | 0.0 | $484k | 13k | 37.98 | |
| Xencor (XNCR) | 0.0 | $439k | 20k | 21.95 | |
| Zafgen | 0.0 | $461k | 13k | 34.64 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $504k | 28k | 18.33 | |
| OncoGenex Pharmaceuticals | 0.0 | $264k | 113k | 2.33 | |
| Kite Pharma | 0.0 | $384k | 6.3k | 60.95 | |
| Abbvie (ABBV) | 0.0 | $10k | 156.00 | 64.10 |
